92 related articles for article (PubMed ID: 10760094)
1. Association of cyclophilin A with renal brush border membranes: redistribution by cyclosporine A.
Demeule M; Laplante A; Sepehr-Araé A; Murphy GM; Wenger RM; Béliveau R
Kidney Int; 2000 Apr; 57(4):1590-8. PubMed ID: 10760094
[TBL] [Abstract][Full Text] [Related]
2. Transgenic mice overexpressing cyclophilin A are resistant to cyclosporin A-induced nephrotoxicity via peptidyl-prolyl cis-trans isomerase activity.
Hong F; Lee J; Piao YJ; Jae YK; Kim YJ; Oh C; Seo JS; Yun YS; Yang CW; Ha J; Kim SS
Biochem Biophys Res Commun; 2004 Apr; 316(4):1073-80. PubMed ID: 15044094
[TBL] [Abstract][Full Text] [Related]
3. Drug binding to P-glycoprotein is inhibited in normal tissues following SDZ-PSC 833 treatment.
Jetté L; Murphy GF; Béliveau R
Int J Cancer; 1998 May; 76(5):729-37. PubMed ID: 9610733
[TBL] [Abstract][Full Text] [Related]
4. Cyclosporin A treatment induces overexpression of P-glycoprotein in the kidney and other tissues.
Jetté L; Beaulieu E; Leclerc JM; Béliveau R
Am J Physiol; 1996 May; 270(5 Pt 2):F756-65. PubMed ID: 8928836
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporin A blocks muscle differentiation by inducing oxidative stress and inhibiting the peptidyl-prolyl-cis-trans isomerase activity of cyclophilin A: cyclophilin A protects myoblasts from cyclosporin A-induced cytotoxicity.
Hong F; Lee J; Song JW; Lee SJ; Ahn H; Cho JJ; Ha J; Kim SS
FASEB J; 2002 Oct; 16(12):1633-5. PubMed ID: 12207006
[TBL] [Abstract][Full Text] [Related]
6. Expression of multidrug resistance P-glycoprotein in kidney allografts from cyclosporine A-treated patients.
Koziolek MJ; Riess R; Geiger H; Thévenod F; Hauser IA
Kidney Int; 2001 Jul; 60(1):156-66. PubMed ID: 11422747
[TBL] [Abstract][Full Text] [Related]
7. P-glycoprotein is a dimer in the kidney and brain capillary membranes: effect of cyclosporin A and SDZ-PSC 833.
Jetté L; Potier M; Béliveau R
Biochemistry; 1997 Nov; 36(45):13929-37. PubMed ID: 9374872
[TBL] [Abstract][Full Text] [Related]
8. Distribution of heat shock proteins in kidneys of rats after immunosuppressive treatment with cyclosporine A.
Stacchiotti A; Rezzani R; Angoscini P; Corsetti G; Bianchi R
Acta Histochem; 2001 Apr; 103(2):167-77. PubMed ID: 11368098
[TBL] [Abstract][Full Text] [Related]
9. Studies on the nephrotoxicity of aminoglycoside antibiotics and protection from these effects (7): Effect of latamoxef on binding of tobramycin to brush border membranes isolated from rat kidney cortex.
Kojima R; Ito M; Suzuki Y
Jpn J Pharmacol; 1989 Dec; 51(4):465-73. PubMed ID: 2615039
[TBL] [Abstract][Full Text] [Related]
10. The molecular replacement solution and X-ray refinement to 2.8 A of a decameric complex of human cyclophilin A with the immunosuppressive drug cyclosporin A.
Pflügl GM; Kallen J; Jansonius JN; Walkinshaw MD
J Mol Biol; 1994 Dec; 244(4):385-409. PubMed ID: 7990129
[TBL] [Abstract][Full Text] [Related]
11. A new recombinant MnSOD prevents the cyclosporine A-induced renal impairment.
Damiano S; Trepiccione F; Ciarcia R; Scanni R; Spagnuolo M; Manco L; Borrelli A; Capasso C; Mancini R; Schiattarella A; Iervolino A; Zacchia E; Bata-Csere A; Florio S; Anastasio P; Pollastro R; Mancini A; Capasso G
Nephrol Dial Transplant; 2013 Aug; 28(8):2066-72. PubMed ID: 23677648
[TBL] [Abstract][Full Text] [Related]
12. 1alpha,25-dihydroxyvitamin D3 shows strong and additive immunomodulatory effects with cyclosporine A in rat renal allotransplants.
Redaelli CA; Wagner M; Günter-Duwe D; Tian YH; Stahel PF; Mazzucchelli L; Schmid RA; Schilling MK
Kidney Int; 2002 Jan; 61(1):288-96. PubMed ID: 11786111
[TBL] [Abstract][Full Text] [Related]
13. Kidney-specific deletion of multidrug resistance-related protein 2 does not aggravate acute cyclosporine A nephrotoxicity in rats.
Mähler N; Freyer M; Kauschke R; Schlüter T; Steinbach AC; Oswald S; Miehe B; Krebs A; Rettig R; Grisk O
Pharmacogenet Genomics; 2012 Jun; 22(6):408-20. PubMed ID: 21869731
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporine A-induced increase in glomerular cyclic GMP in rats and the involvement of the endothelinB receptor.
Tack I; Marin-Castano E; Bascands JL; Pecher C; Ader JL; Girolami JP
Br J Pharmacol; 1997 Jun; 121(3):433-40. PubMed ID: 9179384
[TBL] [Abstract][Full Text] [Related]
15. Immunofluorescent localization and immunochemical determination of cyclophilin-A with specific rabbit antisera.
Sarris AH; Harding MW; Jiang TR; Aftab D; Handschumacher RE
Transplantation; 1992 Nov; 54(5):904-10. PubMed ID: 1440857
[TBL] [Abstract][Full Text] [Related]
16. Different renal toxicity profiles in the association of cyclosporine and tacrolimus with sirolimus in rats.
Lloberas N; Torras J; Alperovich G; Cruzado JM; Giménez-Bonafé P; Herrero-Fresneda I; Franquesa Ml; Rama I; Grinyó JM
Nephrol Dial Transplant; 2008 Oct; 23(10):3111-9. PubMed ID: 18469305
[TBL] [Abstract][Full Text] [Related]
17. A search for cyclophilin-A gene variants in cyclosporine A-treated renal transplanted patients.
Moscoso-Solorzano GT; Ortega F; Rodríguez I; García-Castro M; Gómez E; Díaz-Corte C; Baltar JM; Alvarez V; Ortiz A; Coto E
Clin Transplant; 2008; 22(6):722-9. PubMed ID: 18673375
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporin treatment alters protein phosphorylation in kidney membranes.
Demeule M; Giroux S; Murphy GF; Béliveau R
Biochem Cell Biol; 1994; 72(3-4):143-51. PubMed ID: 7818848
[TBL] [Abstract][Full Text] [Related]
19. Drug interaction between cyclosporine and mTOR inhibitors in experimental model of chronic cyclosporine nephrotoxicity and pancreatic islet dysfunction.
Piao SG; Bae SK; Lim SW; Song JH; Chung BH; Choi BS; Yang CW
Transplantation; 2012 Feb; 93(4):383-9. PubMed ID: 22267156
[TBL] [Abstract][Full Text] [Related]
20. Direct effect of chronic cyclosporine treatment on collagen III mRNA expression and deposition in rat kidneys.
Ceol M; Anglani F; Vianello D; Murer L; Del Prete D; Forino M; Favaro S; Gambaro G; D'Angelo A
Clin Nephrol; 2000 Apr; 53(4):suppl 8-9. PubMed ID: 10809427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
